Key result
Optimization of sodium removal by peritoneal dialysis is a primary therapeutic target for decongestion in patients with heart failure and cardiorenal syndrome.
Why the study?
Optimization of sodium removal by peritoneal dialysis should be the primary focus for decongestion in heart failure and cardiorenal syndrome.
Tailoring peritoneal dialysis to optimize sodium extraction is a crucial strategy for managing congestion in patients with chronic cardiorenal syndrome.
Answers are grounded in this paper and cite their sources.
PD ultrafiltration may aid volume management in refractory cardiorenal HF; leaves open its comparative efficacy pending prospective trials.
BACKGROUND: Peritoneal dialysis (PD) has emerged as a mechanistically relevant therapeutic option for patients with heart failure (HF), volume overload, and varying degrees of renal dysfunction (i.e., chronic cardiorenal syndrome). Congestion has been identified as a potent ominous prognostic factor in this patient population, outperforming a number of established risk factors. As such, excess fluid removal is recognized as a relevant therapeutic target in this setting. METHODS: Accumulating evidence points to the importance of sodium removal as part of any decongestive strategy because extraction of sodium-free water has little or no impact on the outcomes of these patients. Hence, optimization of sodium removal by PD should be the primary focus in the setting of HF and cardiorenal syndrome, especially if PD is started when the patient still has adequate residual renal function for clearance of waste products. RESULTS: Herein, we provide an overview of approaches that can tailor PD treatment to the patients' characteristics and clinical needs (e.g., choice of PD modality) to fully exploit its decongestive properties. Other methods that could prove helpful in the future will also be briefly discussed. CONCLUSION: While these strategies could help with efficient sodium extraction and volume optimization, future studies are needed to evaluate their impact on the outcomes of this specific patient population.
No takes yet. Share an insight, caveat, or question.
Kazory et al. (2019) conducted a review in Heart failure and chronic cardiorenal syndrome. Optimization of sodium removal by peritoneal dialysis was evaluated. Optimization of sodium removal by peritoneal dialysis is a primary therapeutic target for decongestion in patients with heart failure and cardiorenal syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: